Top
INFORMATION
PRESS RELEASES
- 09 April 2012Memorandum of Understanding concluded with Fuso Pharmaceutical Industries, Ltd. and Kaken Pharmaceutical Co., Ltd. regarding sales of absorbable local hemostat (TDM-621)
- 02 March 2012Clinical study with 3DM’s technology started at School of Medicine, Keio University
- 22 February 2012Clinical trial started in U.S. about dental implant product "Alveolar Rebuilding TDM-711"